RAN and neoplasm: In support to this idea, a report has shown that tumor cells have a steeper mitotic Ran-GTP gradient than normal cells resulting in altered pro-metaphase/metaphase timing (Hasegawa et al., 2013), which in turn can influence cell proliferation (Uetake and Sluder, 2010).